Beacon Capital Management LLC (Tennessee)’s Novavax NVAX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-35
Closed -$3K 937
2022
Q2
$3K Hold
35
﹤0.01% 733
2022
Q1
$3K Buy
+35
New +$3.12K ﹤0.01% 734

Other funds holding NVAX

Beacon Capital Management LLC (Tennessee)'s NVAX Position: Q3 2022 in Review

Beacon Capital Management LLC (Tennessee) sold out of Novavax (NVAX) in Q3 2022, closing a stake of 35 shares — an estimated $3K sold.

Beacon Capital Management LLC (Tennessee) first reported a position in NVAX in Q1 2022 and held it in 2 quarters. The position peaked at $3K in Q2 2022. 254 funds tracked by Wall St. Rank hold NVAX as of Q3 2022.

  • Beacon Capital Management LLC (Tennessee) reported no remaining Novavax position as of Q3 2022 after selling out during the quarter.
  • Beacon Capital Management LLC (Tennessee) sold 35 Novavax shares in Q3 2022, an estimated $3K.
  • Beacon Capital Management LLC (Tennessee) first reported a position in Novavax in Q1 2022 and held it in 2 quarters.
  • Beacon Capital Management LLC (Tennessee)'s Novavax position peaked at $3K in Q2 2022.
  • 254 funds tracked by Wall St. Rank held Novavax as of Q3 2022.

Based on Beacon Capital Management LLC (Tennessee)'s 13F filing for Q3 2022, filed 5 Oct 2022.